MYC and B-cell chronic lymphocytic leukemia: At cellular levels, SGI-1776 exhibited promising biological activity, and the SGI-1776-mediated inhibition of PIMs resulted in the reduction in phospho-S62 Myc and total Myc protein abundance in chronic lymphocytic leukaemia cells [212].